IMPACT OF GOLIMUMAB ON PHYSICAL FUNCTION AND EMPLOYABILITY OF PATIENTS WITH RHEUMATOID ARTHRITIS: 5-YEAR DATA FROM 3 PHASE III CLINICAL TRIALS

被引：0
|
作者：
Han, C. [1 ]
Keystone, E. [2 ]
Fleischmann, R. [3 ]
Smolen, J. [4 ,5 ]
Matteson, E. L. [6 ]
Emery, P. [7 ,8 ]
Genovese, M. [9 ]
Gathany, T. [1 ]
Hsia, E. C. [10 ,11 ]
机构：
[1] Johnson & Johnson Pharmaceut Serv LLC, Malvern, PA USA
[2] Univ Toronto, Toronto, ON, Canada
[3] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[4] Med Univ Vienna, Vienna, Austria
[5] Hietzing Hosp, Vienna, Austria
[6] Mayo Clin, Rochester, NY USA
[7] Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England
[8] Univ Leeds, Leeds, W Yorkshire, England
[9] Stanford Univ, Palo Alto, CA 94304 USA
[10] Janssen Res & Dev LLC, Spring House, PA USA
[11] Univ Penn, Philadelphia, PA 19104 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.2535
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0156
引用
收藏
页码：234 / 234
页数：1
相关论文
共 50 条
  • [31] Long-term safety and efficacy of upadacitinib versus adalimumab in patients with rheumatoid arthritis: 5-year data from the phase 3, randomised SELECT-COMPARE study
    Fleischmann, Roy
    Swierkot, Jerzy
    Penn, Sara K.
    Durez, Patrick
    Bessette, Louis
    Bu, Xianwei
    Khan, Nasser
    Li, Yihan
    Peterfy, Charles G.
    Tanaka, Yoshiya
    Mysler, Eduardo
    RMD OPEN, 2024, 10 (02):
  • [32] Golimumab significantly improves self-reported productivity in patients with rheumatoid arthritis: Results from three phase III studies
    Buchanan, J.
    Fleischmann, R.
    Genovese, M. C.
    Kay, J.
    Hsia, E. C.
    Doyle, M. K.
    Rahman, M. U.
    Han, C.
    Parasuraman, S.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S548 - S549
  • [33] SUMMARY OF NEUTROPENIA IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH SIRUKUMAB IN THE SIRROUND PHASE 3 CLINICAL TRIALS
    Takeuchi, T.
    Tanaka, Y.
    Schiff, M.
    Harigai, M.
    Brown, K.
    Rao, R.
    Fei, K.
    Popik, S.
    Yoshizawa, K.
    Wang, Q.
    Hsu, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 581 - 581
  • [34] Safety of tocilizumab in patients with rheumatoid arthritis: Pooled analysis of five phase 3 clinical trials
    Smolen, Josef S.
    Beaulieu, Andre D.
    Dikranian, Ara
    Fenton, Ira
    Fisheleva, Elena
    Alecock, Emma
    Emery, Paul
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S784 - S784
  • [35] GASTROINTESTINAL SAFETY OF TOCILIZUMAB: DATA FROM PATIENTS WITH RHEUMATOID ARTHRITIS IN ROCHE CLINICAL TRIALS AND CLINICAL PRACTICE
    Van Vollenhoven, Ronald
    Keystone, Edward
    Furie, Richard
    Blesch, Anne
    Wang, Candace D.
    Curtis, Jeffrey R.
    RHEUMATOLOGY, 2010, 49 : I103 - I103
  • [36] Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials
    Ruperto, Nicolino
    Brunner, Hermine I.
    Quartier, Pierre
    Constantin, Tamas
    Wulffraat, Nico M.
    Horneff, Gerd
    Kasapcopur, Ozgur
    Schneider, Rayfel
    Anton, Jordi
    Barash, Judith
    Berner, Reinhard
    Corona, Fabrizia
    Cuttica, Ruben
    Fouillet-desjonqueres, Marine
    Fischbach, Michel
    Foster, Helen E.
    Foell, Dirk
    Radominski, Sebastiao C.
    Ramanan, Athimalaipet V.
    Trauzeddel, Ralf
    Unsal, Erbil
    Levy, Jeremy
    Vritzali, Eleni
    Martini, Alberto
    Lovell, Daniel J.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (12) : 1710 - 1719
  • [37] Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib
    Bird, Paul
    Hall, Stephen
    Nash, Peter
    Connell, Carol A.
    Kwok, Kenneth
    Witcombe, David
    Thirunavukkarasu, Krishan
    RMD OPEN, 2019, 5 (01):
  • [38] WORK PRODUCTIVITY AND DAILY ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS IN FOUR PHASE III RANDOMIZED CLINICAL TRIALS OF BARICITINIB
    Smolen, J. S.
    DeLozier, A. M.
    de Bono, S.
    Yang, L.
    Gaich, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 416 - 416
  • [39] Safety and Efficacy of Subcutaneous Golimumab in Patients with Active Rheumatoid Arthritis despite Methotrexate Therapy: Final 5-year Results of the GO-FORWARD Trial
    Keystone, Edward C.
    Genovese, Mark C.
    Hall, Stephen
    Bae, Sang-Cheol
    Han, Chenglong
    Gathany, Timothy A.
    Xu, Stephen
    Zhou, Yiying
    Leu, Jocelyn H.
    Hsia, Elizabeth C.
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (02) : 298 - 306
  • [40] Immunogenicity of sarilumab and impact on safety and efficacy in Japanese patients with rheumatoid arthritis: analysis of two Phase 3 randomised clinical trials
    Tanaka, Yoshiya
    Takahashi, Toshiya
    Sumi, Mariko
    Hagino, Owen
    Van Hoogstraten, Hubert
    Xu, Christine
    Kato, Naoto
    Kameda, Hideto
    MODERN RHEUMATOLOGY, 2022, 32 (04) : 686 - 695
12345